• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型钙拮抗剂PN 200 - 110对麻醉猫和狗心肌及局部外周循环的影响。

Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs.

作者信息

Hof R P, Hof A, Scholtysik G, Menninger K

出版信息

J Cardiovasc Pharmacol. 1984 May-Jun;6(3):407-16. doi: 10.1097/00005344-198405000-00006.

DOI:10.1097/00005344-198405000-00006
PMID:6202965
Abstract

The effects of PN 200-110 (PN), isopropyl 4-(2,1,3- benzoxadiazol -4-yl)-1,4-dihydro-5-methoxycarbonyl-2,6-dim ethyl-3- pyridinecarboxylate , on the cardiovascular system were investigated. In chloralose-urethane-anesthetized cats PN decreased blood pressure (BP) and heart rate (HR) and increased cardiac output (CO) and total peripheral resistance dose dependently after intravenous doses of 1-10 micrograms/kg. Regional blood flow changes effected by an intravenous dose of 10 micrograms/kg were measured with microspheres. Flow to the heart, brain, and skeletal muscle increased selectively, and intramyocardial flow was redistributed in favor of the left ventricular subepicardial layer. The duration of action differed for various effects. The bradycardia was short lasting, and the cerebral vasodilatation persisted longest. It was not possible to predict the duration of action of PN on different target tissues by observing only one variable such as BP. Chloralose-urethane-anesthetized open-chest dogs appeared to be more sensitive to PN than cats. A dose of 3 micrograms/kg i.v. markedly increased coronary flow, lowered BP, increased CO, and tended to lower HR and to increase myocardial contractility. Myocardial oxygen consumption was lowered. PN did not alter diastolic excitation threshold or any electrocardiographic intervals in closed-chest anesthetized dogs. Absence of myocardial depression, potent vasodilator activity, and long duration of action might render PN useful for the treatment of hypertension and angina pectoris.

摘要

研究了PN 200 - 110(PN),即4 -(2,1,3 - 苯并恶二唑 - 4 - 基)- 1,4 - 二氢 - 5 - 甲氧基羰基 - 2,6 - 二甲基 - 3 - 吡啶羧酸异丙酯对心血管系统的影响。在氯醛糖 - 乌拉坦麻醉的猫中,静脉注射剂量为1 - 10微克/千克后,PN剂量依赖性地降低血压(BP)和心率(HR),并增加心输出量(CO)和总外周阻力。用微球测量静脉注射10微克/千克剂量后引起的局部血流变化。流向心脏、大脑和骨骼肌的血流量选择性增加,心肌内血流重新分布,有利于左心室心外膜下层。不同效应的作用持续时间不同。心动过缓持续时间短,脑血管扩张持续时间最长。仅通过观察一个变量(如BP)无法预测PN对不同靶组织的作用持续时间。氯醛糖 - 乌拉坦麻醉的开胸犬似乎比猫对PN更敏感。静脉注射3微克/千克的剂量显著增加冠状动脉血流量,降低血压,增加心输出量,并倾向于降低心率和增加心肌收缩力。心肌耗氧量降低。PN在闭胸麻醉犬中不改变舒张期兴奋阈值或任何心电图间期。缺乏心肌抑制作用、强大的血管舒张活性和较长的作用持续时间可能使PN对治疗高血压和心绞痛有用。

相似文献

1
Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs.新型钙拮抗剂PN 200 - 110对麻醉猫和狗心肌及局部外周循环的影响。
J Cardiovasc Pharmacol. 1984 May-Jun;6(3):407-16. doi: 10.1097/00005344-198405000-00006.
2
Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.钙拮抗剂伊拉地平与其他一些二氢吡啶衍生物对麻醉开胸犬局部血流的比较作用。
Arch Int Pharmacodyn Ther. 1988 Jul-Aug;294:159-74.
3
Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.强效长效1,4 - 二氢吡啶类钙通道阻滞剂OPC - 13340对犬的心血管作用
Arch Int Pharmacodyn Ther. 1993 Jan-Feb;321:41-56.
4
Stereoselectivity at the calcium channel: different profiles of hemodynamic activity of the enantiomers of the dihydropyridine derivative PN 200-110.钙通道的立体选择性:二氢吡啶衍生物PN 200 - 110对映体的不同血流动力学活性特征。
J Cardiovasc Pharmacol. 1986 Mar-Apr;8(2):221-6. doi: 10.1097/00005344-198603000-00001.
5
Effect of PY 108-068, a new calcium antagonist, on general hemodynamics and regional blood flow in anesthetized cats: a comparison with nifedipine.新型钙拮抗剂PY 108 - 068对麻醉猫的一般血流动力学和局部血流的影响:与硝苯地平的比较
J Cardiovasc Pharmacol. 1982 May-Jun;4(3):352-62. doi: 10.1097/00005344-198205000-00003.
6
Cardiovascular effects of the new calcium antagonist isradipine and of diltiazem in anesthetized open-chest dogs.新型钙拮抗剂伊拉地平与地尔硫䓬对麻醉开胸犬的心血管效应
Arzneimittelforschung. 1988 Dec;38(12):1792-6.
7
Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.新型钙拮抗剂莫那普利对动物心脏功能及心肌氧供需的影响。
Arzneimittelforschung. 1993 Dec;43(12):1303-9.
8
Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits.钙拮抗剂对麻醉兔外周循环中血管加压素和血管紧张素II诱导变化的影响
Br J Pharmacol. 1985 May;85(1):75-87. doi: 10.1111/j.1476-5381.1985.tb08833.x.
9
Cardiovascular effects of a new dihydropyridine calcium antagonist.一种新型二氢吡啶类钙拮抗剂的心血管效应
Arzneimittelforschung. 1986 Sep;36(9):1336-44.
10
PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.PN 200 - 110,一种新型钙拮抗剂:对豚鼠心肌组织的电生理、变力性和变时性作用以及对兔主动脉收缩和钙摄取的影响。
J Cardiovasc Pharmacol. 1984 May-Jun;6(3):399-406.

引用本文的文献

1
Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring.非洛地平缓释片早晚服用治疗原发性高血压:一项采用24小时动态监测的双盲研究
Br J Clin Pharmacol. 1993 Jan;35(1):51-4. doi: 10.1111/j.1365-2125.1993.tb05670.x.
2
Preliminary investigations of the clinical pharmacology of three short-acting non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487.三种短效非去极化神经肌肉阻滞剂Org 9453、Org 9489和Org 9487的临床药理学初步研究。
Can J Anaesth. 1994 Mar;41(3):213-20. doi: 10.1007/BF03009833.
3
Effect of the K+ efflux stimulating vasodilator BRL 34915 on 86Rb+ efflux and spontaneous activity in guinea-pig portal vein.
钾离子外流刺激血管扩张剂BRL 34915对豚鼠门静脉86Rb+外流及自发活动的影响
Br J Pharmacol. 1987 Jul;91(3):569-78. doi: 10.1111/j.1476-5381.1987.tb11250.x.
4
Influence of calcium entry blockade on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of hypertensive patients.钙通道阻滞对高血压患者前臂α1和α2肾上腺素能受体介导的血管收缩的影响。
Eur J Clin Pharmacol. 1987;32(2):115-20. doi: 10.1007/BF00542182.
5
Efficacy of the calcium antagonist isradipine in angina pectoris.钙拮抗剂伊拉地平治疗心绞痛的疗效。
Cardiovasc Drugs Ther. 1988 Mar;1(6):661-4. doi: 10.1007/BF02125752.
6
Cardiovascular effects of two new calcium antagonists, PY 108-068 and PN 200-110, in conscious spontaneously hypertensive rats.两种新型钙拮抗剂PY 108 - 068和PN 200 - 110对清醒自发性高血压大鼠的心血管效应。
Br J Pharmacol. 1988 Jan;93(1):176-84. doi: 10.1111/j.1476-5381.1988.tb11419.x.
7
Pharmacokinetics of PN 200-110 (isradipine), a new calcium antagonist, after oral administration in man.新型钙拮抗剂PN 200 - 110(伊拉地平)在人体口服后的药代动力学
Eur J Clin Pharmacol. 1987;32(4):361-5. doi: 10.1007/BF00543970.
8
Cardioprotection by the calcium antagonist PN 200-110 in the absence and presence of cardiodepression.在存在和不存在心脏抑制的情况下,钙拮抗剂PN 200 - 110的心脏保护作用。
Br J Pharmacol. 1985 Sep;86(1):181-9. doi: 10.1111/j.1476-5381.1985.tb09448.x.
9
Acute calcium entry blockade inhibits the blood pressure but not the hormonal responses to angiotensin II.急性钙内流阻断可抑制血压,但不影响对血管紧张素II的激素反应。
Eur J Clin Pharmacol. 1989;36(6):567-73. doi: 10.1007/BF00637737.
10
Experimental studies with isradipine in stroke.关于伊拉地平在中风方面的实验研究。
Drugs. 1990;40 Suppl 2:44-51. doi: 10.2165/00003495-199000402-00012.